Press Releases Filter Filter Results Year 2025 (2) 2024 (5) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (24) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) July 1, 2020 Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist June 16, 2020 Abiomed Launches Virtual Physician Education Program, CAMP PCI, to Improve High-Risk PCI Patient Outcomes June 15, 2020 Abiomed Appoints New Chief Medical Officer Charles Simonton, M.D. June 5, 2020 FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump June 3, 2020 Abiomed to Hold Fireside Chat at the William Blair 40th Annual Growth Stock Conference June 1, 2020 FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure May 27, 2020 Abiomed to Hold Fireside Chat at Jefferies Virtual Healthcare Conference May 20, 2020 Abiomed to Host Virtual Clinical Data and Innovation Day May 19, 2020 PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI April 30, 2020 Abiomed Announces Q4 FY 2020 Revenue of $207 Million and 28.1% Operating Margin April 29, 2020 Abiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology (ECMO) to Improve Outcomes for Patients April 10, 2020 Abiomed Fourth Quarter Fiscal 2020 Earnings and Conference Call Notification March 25, 2020 Abiomed’s Response to the COVID-19 Pandemic February 6, 2020 Abiomed Announces Q3 FY 2020 Revenue of $222 Million and 31.7% Operating Margin January 13, 2020 Abiomed Announces Preliminary Q3 FY 2020 Revenue of $222 Million, up 10% Over Prior Year … 5 6 7 8 …
